The new guidance marks a major shift from previous policy, which recommended annual COVID-19 shots for all Americans six months and older.
Breakdown
- FDA approves updated COVID-19 vaccines from Pfizer, Moderna, and Novavax.
- Vaccines now recommended only for seniors or those with high-risk conditions. 11s
- Pfizer's vaccine no longer available for children under 5; Moderna's limited to high-risk young children. 19s
- Distribution of new vaccines may be delayed and depends on insurers, pharmacies, and authorities. 39s
- Healthy adults and children may face barriers and out-of-pocket costs over $150. 48s